(Q37738205)

22 August 2017

title

Scaling up of intermittent preventive treatment of malaria in pregnancy using sulphadoxine-pyrimethamine: prospects and challenges (English)

1 reference

pregnancy-associated malaria

22 August 2017

0 references

0 references

0 references

1 reference

inferred from title

author name string

Wellington Aghoghovwia Oyibo

series ordinal

1

1 reference

22 August 2017

Chimere Obiora Agomo

series ordinal

2

1 reference

22 August 2017

publication date

1 May 2011

1 reference

Maternal and Child Health Journal

22 August 2017

published in

1 reference

22 August 2017

volume

15

1 reference

22 August 2017

issue

4

1 reference

22 August 2017

page(s)

542-552

1 reference

Weekly chloroquine prophylaxis and the effect on maternal haemoglobin status at delivery

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Is chloroquine chemoprophylaxis still effective to prevent low birth weight? Results of a study in Benin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

High prevalence of Plasmodium falciparum pfcrt K76T mutation in pregnant women taking chloroquine prophylaxis in Senegal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Assessing malaria burden during pregnancy in Mali.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Failure of a chloroquine chemoprophylaxis program to adequately prevent malaria during pregnancy in Koupéla District, Burkina Faso

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Lack of efficacy of pyrimethamine prophylaxis in pregnant Nigerian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Antimalarial drug toxicity: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Safety, efficacy and determinants of effectiveness of antimalarial drugs during pregnancy: implications for prevention programmes in Plasmodium falciparum-endemic sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Importance and prevention of malaria in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Case management of malaria in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Molecular cloning and sequence analysis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Implementation of intermittent preventive treatment in pregnancy with sulphadoxine/pyrimethamine (IPTp-SP) at a district health centre in rural Senegal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

A community-based delivery system of intermittent preventive treatment of malaria in pregnancy and its effect on use of essential maternity care at health units in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Intermittent preventive treatment with sulphadoxine-pyrimethamine is effective in preventing maternal and placental malaria in Ibadan, south-western Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Impact of a double dose of sulphadoxine-pyrimethamine to reduce prevalence of pregnancy malaria in southern Mozambique

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Effectiveness of intermittent preventive treatment with sulphadoxine-pyrimethamine for control of malaria in pregnancy in western Kenya: a hospital-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Intermittent sulfadoxine-pyrimethamine in pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi, in 1997-99.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

The evolution of drug-resistant malaria: the role of drug elimination half-life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Potential impact of intermittent preventive treatment (IPT) on spread of drug-resistant malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Association between the pharmacokinetics and in vivo therapeutic efficacy of sulfadoxine-pyrimethamine in Malawian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Effect of intermittent treatment with amodiaquine on anaemia and malarial fevers in infants in Tanzania: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

The dihydrofolate reductase-thymidylate synthetase gene in the drug resistance of malaria parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

A randomized controlled trial of folate supplementation when treating malaria in pregnancy with sulfadoxine-pyrimethamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

De novo and salvage biosynthesis of pteroylpentaglutamates in the human malaria parasite, Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Transfection studies to explore essential folate metabolism and antifolate drug synergy in the human malaria parasite Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Folic acid metabolism and malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Effect of folate derivatives on the activity of antifolate drugs used against malaria and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Reaching the Abuja target for intermittent preventive treatment of malaria in pregnancy in African women: a review of progress and operational challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Intermittent preventive treatment for the prevention of malaria during pregnancy in high transmission areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

The effect of health care worker training on the use of intermittent preventive treatment for malaria in pregnancy in rural western Kenya.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Knowledge and utilization of intermittent preventive treatment for malaria among pregnant women attending antenatal clinics in primary health care centers in rural southwest, Nigeria: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Inferiority of single-dose sulfadoxine-pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Completing the public health HIV/AIDS alphabet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Implementation of intermittent preventive treatment with sulphadoxine-pyrimethamine for control of malaria in pregnancy in Kisumu, western Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Antimalarial Drug Toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Challenges in the concurrent management of malaria and HIV in pregnancy in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Adverse events from drug therapy for human immunodeficiency virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Embryotoxicity of the artemisinin antimalarials and potential consequences for use in women in the first trimester

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

A randomized controlled pilot trial of azithromycin or artesunate added to sulfadoxine-pyrimethamine as treatment for malaria in pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Successful double-blinded, randomized, placebo-controlled field trial of azithromycin and doxycycline as prophylaxis for malaria in western Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Pregnancy outcome following gestational exposure to azithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10995-010-0608-5

Does cotrimoxazole prophylaxis for the prevention of HIV-associated opportunistic infections select for resistant pathogens in Kenyan adults?

21 January 2018

1 reference

12 December 2020

Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection.

1 reference

12 December 2020

Intermittent presumptive treatment for malaria

1 reference

12 December 2020

The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi.

1 reference

12 December 2020

Pharmacokinetics of sulfadoxine and pyrimethamine in intermittent preventive treatment of malaria in pregnancy

1 reference

12 December 2020

Plasma concentrations in pyrimethamine and sulfadoxine and evaluation of pharmacokinetic data by computerized curve fitting.

1 reference

12 December 2020

Systematic review of the safety of trimethoprim-sulfamethoxazole for prophylaxis in HIV-infected pregnant women: implications for resource-limited settings

1 reference

12 December 2020

Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso.

1 reference

12 December 2020

Insecticide-treated nets for preventing malaria in pregnancy

1 reference

12 December 2020

From the Centers for Disease Control. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with HIV

1 reference

12 December 2020

The use of anti-malarial drugs to prevent malaria in the population of malaria-endemic areas.

1 reference

12 December 2020

A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens

1 reference

12 December 2020

Folate and human reproduction

1 reference

12 December 2020

Severe cutaneous reactions to sulfadoxine-pyrimethamine and trimethoprim-sulfamethoxazole in Blantyre District, Malawi

1 reference

12 December 2020

Post-marketing surveillance of prophylactic mefloquine (Lariam) use in pregnancy.

1 reference

12 December 2020

Randomized clinical trial of two malaria prophylaxis regimens for pregnant women in Faladie, Mali

1 reference

12 December 2020

The effects of Plasmodium falciparum and P. vivax infections on placental histopathology in an area of low malaria transmission

1 reference

12 December 2020

A comparison of sulfadoxine-pyrimethamine with chloroquine and pyrimethamine for prevention of malaria in pregnant Nigerian women.

1 reference

12 December 2020

WHO Expert Committee on Malaria. Eighteenth report

1 reference

12 December 2020

The effect of malaria and malaria prevention in pregnancy on offspring birthweight, prematurity, and intrauterine growth retardation in rural Malawi.

1 reference

12 December 2020

Plasmodium falciparum: selection of serine 108 of dihydrofolate reductase during treatment of uncomplicated malaria with co-trimoxazole in Ugandan children

1 reference

12 December 2020

Malaria in pregnancy before and after the implementation of a national IPTp program in Gabon.

1 reference

12 December 2020

10.1007/S10995-010-0608-5

Identifiers

DOI

1 reference

22 August 2017

1 reference